Client News

Mainz Biomed Announces Live Launch of ColoAlert® with testDNA Laboratory in Poland

Abivax secures up to EUR 150m from two structured debt financing transactions

Medigene AG Reports Second Quarter and Six Months 2023 Financial Results and Provides Corporate Update

Mainz Biomed Announces Financial Half Year Results 2023 and Provides Corporate Update

InflaRx Reports Second Quarter 2023 Financial Results & Operating Update

Newron announces H1 2023 results and provides R&D update

Mainz Biomed Announces Live Launch of ColoAlert® with Marylebone Laboratory in the United Kingdom

Destiny Pharma: Publication of new data demonstrates significantly superior efficacy of XF-73 compared to a leading topical antibiotic against MRSA in skin infection models

Tillotts Pharma and TVM Capital Life Science Announce Formation of Mage Biologics to Develop Innovative Oral Antibody Therapy for Ulcerative Colitis

Destiny Pharma: Board changes including appointment of new CEO